Roche announced today the Global Access Program is expanding beyond HIV, to include Mycobacterium tuberculosis (MTB), Hepatitis B and C (HBV and HCV), and Human Papillomavirus (HPV) for low and middle income country programs where the disease burden is the highest.
Related topics
| Topic | Replies | Views | Activity | |
|---|---|---|---|---|
| Global Fund, USAID and Stop TB Partnership's New Collaboration With Molbio Diagnostics Will Increase Access to Rapid Molecular Tests for TB | 0 | 290 | March 10, 2023 | |
| A rapid TB test for people living with HIV | 0 | 456 | June 26, 2019 | |
| Time for $5: GeneXpert diagnostic tests | 0 | 765 | December 12, 2019 | |
| The integration of tuberculosis and HIV testing on GeneXpert can substantially improve access and same-day diagnosis and benefit tuberculosis programmes | 0 | 471 | January 26, 2023 | |
| Global Fund, Stop TB Partnership and USAID Announce New Collaboration with Danaher to Reduce Price and Increase Access to Cepheid’s TB Test | 0 | 421 | September 20, 2023 |